Larvol Delta - Aptinyx-Completes-Enrollment-in-Phase-2b-Study-of-NYX2925-in-Painful-Diabetic-Peripheral-Neuropathy

NYX-2925 - Aptinyx

https://www.businesswire.com/news/home/20211027005260/en/Aptinyx-Completes-Enrollment-in-Phase-2b-Study-of-NYX-2925-in-Painful-Diabetic-Peripheral-Neuropathy

Oct 27, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next